Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБОУ ВО «Омский государственный медицинский университет» Минздрава России, Омск, Россия
Список исп. литературыСкрыть список 1. Сологуб Т.В., Осиновец О.Ю. Иммуномодуляторы в комплексной терапии ОРВИ: возможности применения препарата галавит. Русский медицинский журнал. Медицинское обозрение. 2013; 3 (21): 144–6. URL: https://www.elibrary.ru/item.asp?id=20196494& [Sologub T.V., Osinovec O.Yu. Immunomodulyatori v kompleksnoi terapii ORVI: vozmozhnosti primeneniya preparata galavit. Russkii medicinskii zhurnal. Medicinskoe obozrenie. 2013; 3 (21): 144–6. URL: https://www.elibrary.ru/item.asp?id=20196494& (in Russian).] 2. Трухан Д.И., Филимонов С.Н. Дифференциальный диагноз основных пульмонологических симптомов и синдромов. СПб: СпецЛит, 2019. URL: https://www.elibrary.ru/item.asp?id=41392166 [Truhan D.I., Filimonov S.N. Differencialnii diagnoz osnovnih pulmonologicheskih simptomov i sindromov. Saint Petersburg: SpecLit, 2019. URL: https://www.elibrary.ru/item.asp?id=41392166 (in Russian).] 3. Профилактика, диагностика и лечение новой коронавирусной инфекции COVID-19. Временные методические рекомендации. Версия 16 (18.08.2022). Утв. Минздравом России. URL: https://profilaktika.su/metodicheskie-rekomendatsii-po-koronavirusu-covid-19-ot-18-08-2022-versiya-16/ [Profilaktika, diagnostika i lechenie novoi koronavirusnoi infekcii COVID-19. Vremennie metodicheskie rekomendacii. Versiya 16 (18.08.2022). Utv. Minzdravom Rossii. URL: https://profilaktika. su/metodicheskie-rekomendatsii-po-koronavirusu-covid-19-ot-18-08-2022-versiya-16/ (in Russian).] 4. Tay MZ, Poh CM, Renia L et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 2020; 20 (6): 363–74. DOI: 10.1038/s41577-020-0311-8 5. Blanco-Melo D, Nilsson-Payant BE, Liu WC et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 2020; 181 (5): 1036–45.e9. DOI: 10.1016/j.cell.2020.04.026 6. Трухан Д.И., Тарасова Л.В. Особенности клиники и лечения острых респираторных вирусных инфекций в практике врача-терапевта. Врач. 2014; 8: 44–7. URL: https://www.elibrary.ru/ item.asp?id=21905156 [Truhan D.I., Tarasova L.V. Osobennosti kliniki i lecheniya ostrih respiratornih virusnih infekcii v praktike vracha-terapevta. Vrach. 2014; 8: 44–7. URL: https://www.elibrary.ru/item.asp?id= 21905156 (in Russian).] 7. Лыткина И.Н., Малышев Н.А. Профилактика и лечение гриппа и острых респираторных вирусных инфекций среди эпидемиологически значимых групп населения. Клиническая инфектология и паразитология. 2015; 2 (13): 117–24. URL: https://www. elibrary.ru/item.asp?id=23849863 [Litkina I.N., Malishev N.A. Profilaktika i lechenie grippa i ostrih respiratornih virusnih infekcii sredi epidemiologicheski znachimih grupp naseleniya. Klinicheskaya infektologiya i parazitologiya. 2015; 2 (13): 117–24. URL: https://www.elibrary.ru/item.asp?id= 23849863 (in Russian).] 8. Ершов Ф.И., Наровлянский А.Н., Мезенцева М.В. Ранние цитокиновые реакции при вирусных инфекциях. Цитокины и воспаление. 2004; 1: 1–6. URL: https://www.elibrary.ru/item.asp?id=9124398 [Ershov F.I., Narovlyanskii A.N., Mezenceva M.V. Rannie citokinovie reakcii pri virusnih infekciyah. Citokini i vospalenie. 2004; 1: 1–6. URL: https://www.elibrary.ru/item.asp?id=9124398 (in Russian).] 9. Трухан Д.И., Мазуров А.Л., Речапова Л.А. Острые респираторные вирусные инфекции: актуальные вопросы диагностики, профилактики и лечения в практике терапевта. Терапевтический архив. 2016; 11: 76–82. DOI: 10.17116/terarkh2016881176-82 [Truhan D.I., Mazurov A.L., Rechapova L.A. Ostrie respiratornie virusnie infekcii: aktualnie voprosi diagnostiki, profilaktiki i lecheniya v praktike terapevta. Terapevticheskii arhiv. 2016; 11: 76–82. DOI: 10.17116/terarkh2016881176-82 (in Russian).] 10. Трухан Д.И., Багишева Н.В., Мордык А.В., Небесная Е.Ю. Аминодигидрофталазиндион натрия в профилактике, лечении и реабилитации пациентов с заболеваниями органов дыхания. Consilium Medicum. 2021; 23 (3): 296–303. DOI: 10.26442/20751753. 2021.3.200839 [Truhan D.I., Bagisheva N.V., Mordik A.V., Nebesnaya E.YU. Aminodigidroftalazindion natriya v profilaktike, lechenii i reabilitacii pacientov s zabolevaniyami organov dihaniya. Consilium Medicum. 2021; 23 (3): 296–303. DOI: 10.26442/20751753.2021.3.200839 (in Russian).] 11. Гриневич В.Б., Губонина И.В., Дощицин В.Л. и др. Особенности ведения коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19). Национальный Консенсус 2020. Кардиоваскулярная терапия и профилактика. 2020; 19 (4): 2630. DOI: 10.15829/1728-8800-2020-2630 [Grinevich V.B., Gubonina I.V., Dosh'icin V.L. et al. Osobennosti vedeniya komorbidnih pacientov v period pandemii novoi koronavirusnoi infekcii (COVID-19). Nacionalnii Konsensus 2020. Kardiovaskulyarnaya terapiya i profilaktika. 2020; 19 (4): 2630. DOI: 10.15829/1728-8800-2020-2630 (in Russian).] 12. Catalano A, Iacopetta D, Ceramella J et al. Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment? Foods 2022; 11 (18): 2884. DOI: 10.3390/foods11182884 13. Трухан Д.И., Давыдов Е.Л., Чусова Н.А. Нутрицевтики в профилактике, лечении и на этапе реабилитации после новой коронавирусной инфекции (COVID-19). Клинический разбор в общей медицине. 2021; 7: 21–34. DOI: 10.47407/kr2021.2.7.00085 [Truhan D.I., Davidov E.L., Chusova N.A. Nutricevtiki v profilaktike, lechenii i na etape reabilitacii posle novoi koronavirusnoi infekcii (COVID-19). Clinical review for general practice. 2021; 7: 21–34. DOI: 10.47407/kr2021.2.7.00085 (in Russian).] 14. Pecora F, Persico F, Argentiero A et al. The Role of Micronutrients in Support of the Immune Response against Viral Infections. Nutrients 2020; 12 (10): 3198. DOI: 10.3390/nu12103198 15. Jayawardena R, Sooriyaarachchi P, Chourdakis M et al. Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes Metab Syndr 2020; 14 (4): 367–82. DOI: 10.1016/j.dsx.2020.04.015 16. Thirumdas R, Kothakota A, Pandiselvam R et al. Role of food nutrients and supplementation in fighting against viral infections and boosting immunity: A review. Trends Food Sci Technol 2021; 110: 66–77. DOI: 10.1016/j.tifs.2021.01.069 17. Galmés S, Serra F, Palou A. Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework. Nutrients 2020; 12 (9): 2738. DOI: 10.3390/nu12092738 18. Cámara M, Sánchez-Mata MC, Fernández-Ruiz V et al. A Review of the Role of Micronutrients and Bioactive Compounds on Immune System Supporting to Fight against the COVID-19 Disease. Foods 2021; 10 (5): 1088. DOI: 10.3390/foods10051088 19. Calder PC. Nutrition, immunity and COVID-19. BMJ Nutr Prev Health 2020; 3 (1): 74–92. DOI: 10.1136/bmjnph-2020-000085 20. Shakoor H, Feehan J, Al Dhaheri AS et al. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? Maturitas 2021; 143: 1–9. DOI: 10.1016/j.maturitas.2020.08.003 21. Kumar P, Kumar M, Bedi O et al. Role of vitamins and minerals as immunity boosters in COVID-19. Inflammopharmacology 2021; 6: 1–16. DOI: 10.1007/s10787-021-00826-7 22. Subedi L, Tchen S, Gaire BP et al. Adjunctive Nutraceutical Therapies for COVID-19. Int J Mol Sci 2021; 22 (4): 1963. DOI: 10.3390/ijms22041963 23. Farzana M, Shahriar S, Jeba FR et al. Functional food: complementary to fight against COVID-19. Beni Suef Univ J Basic Appl Sci 2022; 11 (1): 33. DOI: 10.1186/s43088-022-00217-z 24. Junaid K, Ejaz H, Abdalla AE et al. Effective Immune Functions of Micronutrients against SARS-CoV-2. Nutrients 2020; 12 (10): 2992. DOI: 10.3390/nu12102992 25. Nedjimi B. Can trace element supplementations (Cu, Se, and Zn) enhance human immunity against COVID-19 and its new variants? Beni Suef Univ J Basic Appl Sci 2021; 10 (1): 33. DOI: 10.1186/s43088-021-00123-w 26. Jan A, Tinkov A, Strand TA et al. Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raising Anti-Viral Resistance Against Progressive COVID-19. Nutrients 2020; 12 (8): 2358. DOI: 10.3390/nu12082358 27. Iddir M, Brito A, Dingeo G et al. Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis. Nutrients 2020; 12 (6): 1562. DOI: 10.3390/nu12061562 28. Clemente-Suárez VJ, Ramos-Campo DJ, Mielgo-Ayuso J et al. Nutrition in the Actual COVID-19 Pandemic. A Narrative Review. Nutrients 2021; 13 (6): 1924. DOI: 10.3390/nu13061924 29. Akhtar S, Das JK, Ismail T et al. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev 2021; 79 (3): 289–300. DOI: 10.1093/nutrit/nuaa063 30. Di Renzo L, Gualtieri P, Pivari F et al. COVID-19: Is there a role for immunonutrition in obese patient? J Transl Med 2020; 18 (1): 415. DOI: 10.1186/s12967-020-02594-4 31. Mrityunjaya M, Pavithra V, Neelam R et al. Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19. Front Immunol 2020; 11: 570122. DOI: 10.3389/fimmu.2020.570122 32. Vahid F, Rahmani D. Can an anti-inflammatory diet be effective in preventing or treating viral respiratory diseases? A systematic narrative review. Clin Nutr ESPEN 2021; 43: 9–15. DOI: 10.1016/ j.clnesp.2021.04.009 33. Jovic TH, Ali SR, Ibrahim N et al. Could Vitamins Help in the Fight Against COVID-19? Nutrients 2020; 12 (9): 2550. DOI: 10.3390/nu12092550 34. Dharmalingam K, Birdi A, Tomo S et al. Trace Elements as Immunoregulators in SARS-CoV-2 and Other Viral Infections. Indian J Clin Biochem 2021; Feb 12: 1–11. DOI: 10.1007/s12291-021-00961-6 35. de Faria Coelho-Ravagnani C, Corgosinho FC et al. Dietary recommendations during the COVID-19 pandemic. Nutr Rev 2021; 79 (4): 382–93. DOI: 10.1093/nutrit/nuaa067 36. Цинк, селен и витамин D. Как защищаться от COVID-19? Коронавирус COVID-19: Официальная информация о коронавирусе в России на портале – стопкоронавирус.рф. URL: https://xn--80aesfpebagmfblc0a.xn--p1ai/news/20201024-1315.html [Cink, selen i vitamin D. Kak zash'ish'atsya ot COVID-19? Koronavirus COVID-19: Oficialnaya informaciya o koronaviruse v Rossii na portale – stopkoronavirus.rf. URL: https://xn--80aesfpebagmfblc0a.xn--p1ai/news/20201024-1315.html (in Russian).] 37. Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection Am J Clin Nutr 1998; 68 (Suppl. 2): 447S–463S. DOI: 10.1093/ajcn/68.2.447S 38. Li J, Cao D, Huang Y et al. Zinc Intakes and Health Outcomes: An Umbrella Review. Front Nutr 2022; 9: 798078. DOI: 10.3389/fnut.2022.798078 39. Samad N, Sodunke TE, Abubakar AR et al. The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic. J Inflamm Res 2021; 14: 527–50. DOI: 10.2147/JIR.S295377 40. Corrao S, Mallaci Bocchio R, Lo Monaco M et al. Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc. Nutrients 2021; 13 (4): 1261. DOI: 10.3390/nu13041261 41. Vlieg-Boerstra B, de Jong N, Meyer R et al. Nutrient supplementation for prevention of viral respiratory tract infections in healthy subjects: A systematic review and meta-analysis. Allergy 2022; 77 (5): 1373–88. DOI: 10.1111/all.15136 42. Patel O, Chinni V, El-Khoury J et al. A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients. J Med Virol 2021; 93 (5): 3261–7. 43. Scarpellini E, Balsiger LM, Maurizi V et al. Zinc and gut microbiota in health and gastrointestinal disease under the COVID-19 suggestion. Biofactors 2022; 48 (2): 294–306. DOI: 10.1002/biof.1829 44. Skalny AV, Rink L, Ajsuvakova OP et al. Zinc and respiratory tract infections: Perspectives for COVID-19 (Review). Int J Mol Med 2020; 46 (1): 17–26. DOI: 10.3892/ijmm.2020.4575 45. Han YS, Chang GG, Juo CG et al. Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition. Biochemistry 2005; 44 (30): 10349–59. DOI: 10.1021/bi0504761 46. Rieder AS, Deniz BF, C Netto CA, Wyse ATS. A Review of In Silico Research, SARS-CoV-2, and Neurodegeneration: Focus on Papain-Like Protease. Neurotox Res 2022; 40 (5): 1553–69. DOI: 10.1007/s12640-022-00542-2 47. Jothimani D, Kailasam E, Danielraj S et al. COVID-19: Poor outcomes in patients with zinc deficiency. Int J Infect Dis 2020; 100: 343–9. DOI: 10.1016/j.ijid.2020.09.014 48. Wessels I, Rolles B, Rink L. The Potential Impact of Zinc Supplementation on COVID-19. Pathogenesis. Front Immunol 2020; 11: 1712. DOI: 10.3389/fimmu.2020.01712 49. Heller RA, Sun Q, Hackler J et al. Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker. Redox Biol 2021; 38: 101764. DOI: 10.1016/j.redox.2020.101764 50. Wessels I, Rolles B, Slusarenko AJ, Rink L. Zinc deficiency as a possible risk factor for increased susceptibility and severe progression of Corona Virus Disease 19. Br J Nutr 2022; 127 (2): 214–32. DOI: 10.1017/S0007114521000738 51. Marreiro DDN, Cruz KJC, Oliveira ARS et al. Antiviral and immunological activity of zinc and possible role in COVID-19. Br J Nutr 2022; 127 (8): 1172–9. DOI: 10.1017/S0007114521002099 52. Rahman MT, Idid SZ. Can Zn Be a Critical Element in COVID-19 Treatment? Biol Trace Elem Res 2021; 199 (2): 550–8. DOI: 10.1007/s12011-020-02194-9 53. de Almeida Brasiel PG. The key role of zinc in elderly immunity: A possible approach in the COVID-19 crisis. Clin Nutr ESPEN 2020; 38: 65–6. DOI: 10.1016/j.clnesp.2020.06.003 54. Hunter J, Arentz S, Goldenberg J et al. Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials. BMJ Open 2021; 11 (11): e047474. DOI: 10.1136/bmjopen-2020-047474 55. Imran M, Fatima W, Alzahrani AK et al. Development of Therapeutic and Prophylactic Zinc Compositions for Use against COVID-19: A Glimpse of the Trends, Inventions, and Patents. Nutrients 2022; 14 (6): 1227. DOI: 10.3390/nu14061227 56. Pedrosa LFC, Barros ANAB, Leite-Lais L. Nutritional risk of vitamin D, vitamin C, zinc, and selenium deficiency on risk and clinical outcomes of COVID-19: A narrative review. Clin Nutr ESPEN 2022; 47: 9–27. DOI: 10.1016/j.clnesp.2021.11.003 57. Pechlivanidou E, Vlachakis D, Tsarouhas K et al. The prognostic role of micronutrient status and supplements in COVID-19 outcomes: A systematic review. Food Chem Toxicol 2022; 162: 112901. DOI: 10.1016/j.fct.2022.112901 58. Sadeghsoltani F, Mohammadzadeh I, Safari MM et al. Zinc and Respiratory Viral Infections: Important Trace Element in Anti-viral Response and Immune Regulation. Biol Trace Elem Res 2022; 200 (6): 2556–71. DOI: 10.1007/s12011-021-02859-z 59. Tabatabaeizadeh SA. Zinc supplementation and COVID-19 mortality: a meta-analysis. Eur J Med Res 2022; 27 (1): 70. DOI: 10.1186/s40001-022-00694-z 60. Martinez SS, Huang Y, Acuna L et al. Role of Selenium in Viral Infections with a Major Focus on SARS-CoV-2. Int J Mol Sci 2021; 23 (1): 280. DOI: 10.3390/ijms23010280 61. Barchielli G, Capperucci A, Tanini D. The Role of Selenium in Pathologies: An Updated Review. Antioxidants (Basel) 2022; 11 (2): 251. DOI: 10.3390/antiox11020251 62. Moghaddam A, Heller RA, Sun Q et al. Selenium Deficiency Is Associated with Mortality Risk from COVID-19. Nutrients 2020; 12 (7): 2098. DOI: 10.3390/nu12072098 63. Bae M, Kim H. Mini-Review on the Roles of Vitamin C, Vitamin D, and Selenium in the Immune System against COVID-19. Molecules 2020; 25 (22): 5346. DOI: 10.3390/molecules25225346 64. Bermano G, Méplan C, Mercer DK, Hesketh JE. Selenium and viral infection: are there lessons for COVID-19? Br J Nutr 2021; 125 (6): 618–27. DOI: 10.1017/S0007114520003128 65. Khatiwada S, Subedi A. A Mechanistic Link Between Selenium and Coronavirus Disease 2019 (COVID-19). Curr Nutr Rep 2021; 10 (2): 125–36. DOI: 10.1007/s13668-021-00354-4 66. Tomo S, Saikiran G, Banerjee M, Paul S. Selenium to selenoproteins – role in COVID-19. EXCLI J 2021; 20: 781–91. DOI: 10.17179/excli2021-3530 67. Fakhrolmobasheri M, Mazaheri-Tehrani S, Kieliszek M et al. COVID-19 and Selenium Deficiency: a Systematic Review. Biol Trace Elem Res 2022; 200 (9): 3945–56. DOI: 10.1007/s12011-021-02997-4 68. Alshammari MK, Fatima W, Alraya RA et al. Selenium and COVID-19: A spotlight on the clinical trials, inventive compositions, and patent literature. J Infect Public Health 2022; 15 (11): 1225–33. DOI: 10.1016/j.jiph.2022.09.011 69. Schomburg L. Selenium Deficiency in COVID-19-A Possible Long-Lasting Toxic Relationship. Nutrients 2022; 14 (2): 283. DOI: 10.3390/nu14020283 70. Schomburg L. Selenoprotein P – Selenium transport protein, enzyme and biomarker of selenium status. Free Radic Biol Med 2022; 191: 150–63. DOI: 10.1016/j.freeradbiomed.2022.08.022 71. Lima LW, Nardi S, Santoro V, Schiavon M. The Relevance of Plant-Derived Se Compounds to Human Health in the SARS-CoV-2 (COVID-19) Pandemic Era. Antioxidants (Basel) 2021; 10 (7): 1031. DOI: 10.3390/antiox10071031 72. Im JH, Je YS, Baek J et al. Nutritional status of patients with COVID-19. Int J Infect Dis 2020; 100: 390–3. DOI: 10.1016/j.ijid.2020.08.018 73. Younesian O, Khodabakhshi B, Abdolahi N et al. Decreased Serum Selenium Levels of COVID-19 Patients in Comparison with Healthy Individuals. Biol Trace Elem Res 2021; Jul 1: 1–6. DOI: 10.1007/s12011-021-02797-w 74. Skesters A, Kustovs D, Lece A et al. Selenium, selenoprotein P, and oxidative stress levels in SARS-CoV-2 patients during illness and recovery. Inflammopharmacology 2022; 30 (2): 499–503. DOI: 10.1007/s10787-022-00925-z 75. Zhang J, Saad R, Taylor EW, Rayman MP. Selenium and selenoproteins in viral infection with potential relevance to COVID-19. Redox Biol 2020; 37: 101715. DOI: 10.1016/j.redox.2020.101715 76. Oliveira CR, Viana ET, Gonçalves TF et al. Therapeutic use of intravenous selenium in respiratory and immunological diseases: evidence based on reviews focused on clinical trials. Adv Respir Med 2022. DOI: 10.5603/ARM.a2022.0018 77. Khatiwada S, Subedi A. A Mechanistic Link Between Selenium and Coronavirus Disease 2019 (COVID-19). Curr Nutr Rep 2021; 10 (2): 125–36. DOI: 10.1007/s13668-021-00354-4 78. Majeed M, Nagabhushanam K, Prakasan P, Mundkur L. Can Selenium Reduce the Susceptibility and Severity of SARS-CoV-2?-A Comprehensive Review. Int J Mol Sci 2022; 23 (9): 4809. DOI: 10.3390/ijms23094809 79. Rayman MP, Taylor EW, Zhang J. The relevance of selenium to viral disease with special reference to SARS-CoV-2 and COVID-19. Proc Nutr Soc 2022; Aug 19: 1–12. DOI: 10.1017/S0029665122002646 80. Kieliszek M, Lipinski B. Selenium supplementation in the prevention of coronavirus infections (COVID-19). Med Hypotheses 2020; 143: 109878. DOI: 10.1016/j.mehy.2020.109878 81. Taheri S, Asadi S, Nilashi M et al. A literature review on beneficial role of vitamins and trace elements: Evidence from published clinical studies. J Trace Elem Med Biol 2021; 67: 126789. DOI: 10.1016/j.jtemb.2021.126789 82. Engin AB, Engin ED, Engin A. Can iron, zinc, copper and selenium status be a prognostic determinant in COVID-19 patients? Environ Toxicol Pharmaco 2022; 95: 103937. DOI: 10.1016/j.etap. 2022.103937 83. Fiorino S, Gallo C, Zippi M et al. Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy. Aging Clin Exp Res 2020; 32 (10): 2115–31. DOI: 10.1007/s40520-020-01669-y 84. Abioye AI, Bromage S, Fawzi W. Effect of micronutrient supplements on influenza and other respiratory tract infections among adults: a systematic review and meta-analysis. BMJ Glob Health 2021; 6 (1): e003176. DOI: 10.1136/bmjgh-2020-003176 85. Diyya ASM, Thomas NV. Multiple Micronutrient Supplementation: As a Supportive Therapy in the Treatment of COVID-19. Biomed Res Int 2022; 2022: 3323825. DOI: 10.1155/2022/3323825 86. Shahbaz U, Fatima N, Basharat S et al. Role of vitamin C in preventing of COVID-19 infection, progression and severity. AIMS Microbiol 2022; 8 (1): 108–24. DOI: 10.3934/microbiol.2022010 87. Ebrahimzadeh-Attari V, Panahi G, Hebert JR et al. Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals. Health Promot Perspect 2021; 11 (2): 119–36. DOI: 10.34172/ hpp.2021.17 88. Abobaker A, Alzwi A, Alraied AHA. Overview of the possible role of vitamin C in management of COVID-19. Pharmacol Rep 2020; 72 (6): 1517–28. DOI: 10.1007/s43440-020-00176-1 89. Uddin MS, Millat MS, Baral PK et al. The protective role of vitamin C in the management of COVID-19: A Review. J Egypt Public Health Assoc 2021; 96 (1): 33. DOI: 10.1186/s42506-021-00095-w 90. Carr AC, Gombart AF. Multi-Level Immune Support by Vitamins C and D during the SARS-CoV-2 Pandemic. Nutrients 2022; 14 (3): 689. DOI: 10.3390/nu14030689 91. Holford P, Carr AC, Zawari M, Vizcaychipi MP. Vitamin C Intervention for Critical COVID-19: A Pragmatic Review of the Current Level of Evidence. Life (Basel) 2021; 11 (11): 1166. DOI: 10.3390/ life11111166 92. Hiedra R, Lo KB, Elbashabsheh M et al. The use of IV vitamin C for patients with COVID-19: a case series. Expert Rev Anti Infect Ther 2020; 18 (12): 1259–61. DOI: 10.1080/14787210.2020.1794819 93. Olczak-Pruc M, Swieczkowski D, Ladny JR et al. Vitamin C Supplementation for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Nutrients 2022; 14 (19): 4217. DOI: 10.3390/nu14194217 94. Vollbracht C, Kraft K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C. Front Pharmacol 2022; 13: 899198. DOI: 10.3389/fphar.2022.899198 95. Firouzi S, Pahlavani N, Navashenaq JG et al. The effect of Vitamin C and Zn supplementation on the immune system and clinical outcomes in COVID-19 patients. Clin Nutr Open Sci 2022; 44: 144–54. DOI: 10.1016/j.nutos.2022.06.006 96. Stephensen CB, Lietz G. Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2. Br J Nutr 2021; 126 (11): 1663–72. DOI: 10.1017/S0007114521000246 97. Li R, Wu K, Li Y et al. Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19. Aging (Albany NY) 2020; 12 (15): 15784–96. DOI: 10.18632/aging.103888 98. Tepasse PR, Vollenberg R, Fobker M et al. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Nutrients 2021; 13 (7): 2173. DOI: 10.3390/nu13072173 99. Ebrahimzadeh-Attari V, Panahi G, Hebert JR et al. Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals. Health Promot Perspect 2021; 11 (2): 119–36. DOI: 10.34172/hpp. 2021.17 100. Tavakol S, Seifalian AM. Vitamin E at a high dose as an anti-ferroptosis drug and not just a supplement for COVID-19 treatment. Biotechnol Appl Biochem 2021: 10.1002/bab.2176. DOI: 10.1002/ bab.2176. 101. Lai YJ, Chang HS, Yang YP et al. The role of micronutrient and immunomodulation effect in the vaccine era of COVID-19. J Chin Med Assoc 2021; 84 (9): 821–6. DOI: 10.1097/JCMA. 0000000000000587 102. Rataan AO, Geary SM, Zakharia Y et al. Potential Role of Selenium in the Treatment of Cancer and Viral Infections. Int J Mol Sci 2022; 23 (4): 2215. DOI: 10.3390/ijms23042215 103. Midha IK, Kumar N, Kumar A, Madan T. Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings. Rev Med Virol 2021; 31 (5): 1–14. DOI: 10.1002/rmv.2204 104. Трухан Д.И., Давыдов Е.Л. Место и роль терапевта и врача общей практики в курации коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19): акцент на неспецифическую профилактику. Фарматека. 2021; 10: 34–45. DOI: 10.18565/pharmateca.2021.10.34-45 [Truhan D.I., Davidov E.L. Mesto i rol terapevta i vracha obsh'ei praktiki v kuracii komorbidnih pacientov v period pandemii novoi koronavirusnoi infekcii (COVID-19): akcent na nespecificheskuyu profilaktiku. Farmateka. 2021; 10: 34–45. DOI: 10.18565/pharmateca.2021.10.34-45 (in Russian).] 105. Трухан Д.И., Давыдов Е.Л., Чусова Н.А., Чусов И.С. Возможности терапевта в профилактике и на реабилитационном этапе после новой коронавирусной инфекции (COVID-19) коморбидных пациентов с артериальной гипертензией. Клинический разбор в общей медицине. 2021; 5: 6–15. DOI: 10.47407/kr2021.2.5.00064 [Truhan D.I., Davidov E.L., CHusova N.A., CHusov I.S. Vozmozhnosti terapevta v profilaktike i na reabilitacionnom etape posle novoi koronavirusnoi infekcii (COVID-19) komorbidnih pacientov s arterialnoi gipertenziei. Clinical review for general practice. 2021; 5: 6–15. DOI: 10.47407/kr2021.2.5.00064 (in Russian).] 106. Трухан Д.И., Давыдов Е.Л. Место и роль терапевта и врача общей практики в курации коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19): акцент на реабилитационный этап. Фарматека. 2021; 13: 44–53. DOI: 10.18565/pharmateca.2021.13.44-53 [Truhan D.I., Davidov E.L. Mesto i rol terapevta i vracha obsh'ei praktiki v kuracii komorbidnih pacientov v period pandemii novoi koronavirusnoi infekcii (COVID-19): akcent na reabilitacionnii etap. Farmateka. 2021; 13: 44–53. DOI: 10.18565/pharmateca.2021. 13.44-53 (in Russian).] 107. Борисов В.В. Еще раз о COVID-19 (клиническая лекция). Клинический разбор в общей медицине. 2022; 2: 13–21. DOI: 10.47407/kr2022.3.2.00121 [Borisov V.V. Esh'e raz o COVID-19 (klinicheskaya lekciya). Clinical review for general practice. 2022; 2: 13–21. DOI: 10.47407/ kr2022.3.2.00121 (in Russian).] 108. Борисов В.В. Микроэлементы селен и цинк в организме женщины и мужчины: проблемы и решения. Consilium Medicum. 2018; 20 (7): 63–8. DOI: 10.26442/2075-1753_2018.7.63-68. [Borisov V.V. Mikroelementi selen i cink v organizme zhensh'ini i muzhchini: problemi i resheniya. Consilium Medicum. 2018; 20 (7): 63–8. DOI: 10.26442/2075-1753_2018.7.63-68 (in Russian).] 109. Борисов В.В. Российская демография, пути улучшения мужского и женского здоровья в аспекте фертильности. Мнение уролога и репродуктолога. Consilium Medicum. 2019; 21 (7): 10–8. DOI: 10.26442/20751753.2019.7.190425 [Borisov V.V. Rossiiskaya demografiya, puti uluchsheniya muzhskogo i zhenskogo zdorovya v aspekte fertilnosti. Mnenie urologa i reproduktologa. Consilium Medicum. 2019; 21 (7): 10–8. DOI: 10.26442/20751753.2019.7.190425 (in Russian).] 110. Трухан Д.И., Викторова И.А. Нефрология. Эндокринология. Гематология. СПб: СпецЛит, 2017. URL: https://www.elibrary.ru/ item.asp?id=36478198 [Truhan D.I., Viktorova I.A. Nefrologiya. Endokrinologiya. Gematologiya. Saint Petersburg: SpecLit, 2017. URL: https://www. elibrary.ru/item.asp?id=36478198 (in Russian).] 111. Трухан Д.И., Викторова И.А., Сафонов А.Д. Болезни печени. СПб: СпецЛит, 2019. URL: https://www.elibrary.ru/item. asp?id=41392560 [Truhan D.I., Viktorova I.A., Safonov A.D. Bolezni pecheni. Saint Petersburg: SpecLit, 2019. URL: https://www.elibrary.ru/item. asp?id=41392560 (in Russian).] 112. Тарасова Л.В., Трухан Д.И. Болезни кишечника. Клиника, диагностика и лечение. СПб: СпецЛит, 2022. URL: https://www. elibrary.ru/item.asp?id=49497776 [Tarasova L.V., Truhan D.I. Bolezni kishechnika. Klinika, diagnostika i lechenie. Saint Petersburg: SpecLit, 2022. URL: https:// www.elibrary.ru/item.asp?id=49497776 (in Russian).] 113. Трухан Д.И., Филимонов С.Н., Багишева Н.В. Болезни органов дыхания: актуальные аспекты клиники, диагностики и лечения. СПб: СпецЛит, 2022. URL: https://elibrary.ru/item. asp?id=49459552 [Truhan D.I., Filimonov S.N., Bagisheva N.V. Bolezni organov dihaniya: aktualnie aspekti kliniki, diagnostiki i lecheniya. Saint Petersburg: SpecLit, 2022. URL: https://elibrary.ru/item.asp?id= 49459552 (in Russian).] 114. Mahluji S, Jalili M, Ostadrahimi A et al. Nutritional management of diabetes mellitus during the pandemic of COVID-19: a comprehensive narrative review. J Diabetes Metab Disord 2021; 20 (1): 1–10. DOI: 10.1007/s40200-021-00784-5 115. Venkatesan P. NICE guideline on long COVID. The Lancet Respiratory Medicine 2021; 9 (2): 129. DOI: 10.1016/S2213-2600(21)00031-X 116. Dani M, Dirksen A, Taraborrelli P et al. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med (Lond) 2021; 21 (1): e63–e67. DOI: 10.7861/clinmed.2020-0896 117. Oronsky B, Larson C, Hammond TC et al. A review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol 2021; Feb 20: 1–9. DOI: 10.1007/s12016-021-08848-3 118. Carfì A, Bernabei R, Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324 (6): 603–5. DOI: 10.1001/ jama.2020.12603 119. Townsend L, Dowds J, O'Brien K et al. Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc 2021; Jan 8. DOI: 10.1513/ AnnalsATS.202009-1175OC 120. Huang C, Huang L, Wang Y et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397: 220–32. DOI: 10.1016/S0140-6736(20)32656-8 121. Salamanna F, Veronesi F, Martini L et al. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne) 2021; 8: 653516. DOI: 10.3389/fmed.2021.653516 122. Iqbal FM, Lam K, Sounderajah V et al. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine 2021; 36: 100899. DOI: 10.1016/j.eclinm.2021.100899 123. Wong TL, Weitzer DJ. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina (Kaunas) 2021; 57 (5): 418. DOI: 10.3390/ medicina57050418 124. Hellwig S, Domschke K. Post-COVID syndrome-Focus fatigue. Nervenarzt 2022; 93 (8): 788–96. DOI: 10.1007/s00115-022-01306-1 125. Campagnolo N, Johnston S, Collatz A et al. Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review. J Hum Nutr Diet 2017; 30 (3): 247–59. DOI: 10.1111/jhn.12435 126. Bjørklund G, Dadar M, Pen JJ et al. Chronic fatigue syndrome (CFS): Suggestions for a nutritional treatment in the therapeutic approach. Biomed Pharmacother 2019; 109: 1000–7. DOI: 10.1016/ j.biopha.2018.10.076 127. Maksoud R, Balinas C, Holden S et al. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med 2021; 19 (1): 81. DOI: 10.1186/s12967-021-02742-4 128. Ostojic SM. Diagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome. Nutrients 2021; 13 (2): 503. DOI: 10.3390/nu13020503 129. Logan AC, Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern Med Rev 2001; 6 (5): 450–9. URL: https://pubmed.ncbi.nlm.nih.gov/11703165/ 130. Carod-Artal FJ. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol 2021; 72 (11): 384–96. DOI: 10.33588/rn.7211.2021230 131. Bornstein SR, Voit-Bak K, Donate T et al. Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis? Mol Psychiatry 2022; 27 (1): 34–7. DOI: 10.1038/s41380-021-01148-4 132. Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/ chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med 2021; 27 (9): 895–6. DOI: 10.1016/j.molmed.2021.06.002 133. Tziastoudi M, Cholevas C, Stefanidis I, Theoharides TC. Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review. Ann Clin Transl Neurol 2022. DOI: 10.1002/acn3.51631 134. Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis 2021; 8: 20499361211009385. DOI: 10.1177/20499361211009385 135. Vecchiet J, Cipollone F, Falasca K et al. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett 2003; 2; 335 (3): 151–4. DOI: 10.1016/s0304-3940(02)01058-3 136. Maggini S, Óvári V, Ferreres Giménez I, Pueyo Alamán MG. Benefits of micronutrient supplementation on nutritional status, energy metabolism, and subjective wellbeing. Nutr Hosp 2021; 38 (Spec. №2): 3–8. DOI: 10.20960/nh.03788 137. Maes M, Mihaylova I, De Ruyter M. Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. J Affect Disord 2006; 90 (2–3): 141–7. DOI: 10.1016/j.jad.2005.11.002 138. Castro-Marrero J, Zaragozá MC, López-Vílchez I et al. Effect of Melatonin Plus Zinc Supplementation on Fatigue Perception in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Antioxidants (Basel) 2021; 10 (7): 1010. DOI: 10.3390/antiox10071010 139. Shao C, Song J, Zhao S et al. Therapeutic Effect and Metabolic Mechanism of A Selenium-Polysaccharide from Ziyang Green Tea on Chronic Fatigue Syndrome. Polymers (Basel) 2018; 10 (11): 1269. DOI: 10.3390/polym10111269 140. Beligaswatta C, Sudusinghe D, De Silva S, Davenport A. Prevalence and correlates of low plasma selenium concentrations in peritoneal dialysis patients. J Trace Elem Med Biol 2022; 69: 126899. DOI: 10.1016/j.jtemb.2021.126899 141. Miwa K, Fujita M. Increased oxidative stress suggested by low serum vitamin E concentrations in patients with chronic fatigue syndrome. Int J Cardiol 2009; 136 (2): 238–9. DOI: 10.1016/j.ijcard.2008. 04.051 142. Miwa K, Fujita M. Fluctuation of serum vitamin E (alpha-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome. Heart Vessels 2010; 25 (4): 319–23. DOI: 10.1007/s00380-009-1206-6 143. Joustra ML, Minovic I, Janssens KAM et al. Vitamin and mineral status in chronic fatigue syndrome and fibromyalgia syndrome: A systematic review and meta-analysis. PLoS One 2017; 12 (4): e0176631. DOI: 10.1371/journal.pone.0176631 144. Kodama M, Kodama T. Four problems with the clinical control of interstitial pneumonia, or chronic fatigue syndrome, using the megadose vitamin C infusion system with dehydroepiandrosterone-cortisol annex. In Vivo 2006; 20 (2): 285–91. https://pubmed.ncbi. nlm.nih.gov/16634532/ 145. Butters D, Whitehouse M. COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials. Inflammopharmacology 2021; 29 (1): 101–5. DOI: 10.1007/s10787-020-00774-8 146. Vollbracht C, Kraft K. Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue. Nutrients 2021; 13 (4): 1154. DOI: 10.3390/nu13041154 147. Chivese T, Matizanadzo JT, Musa OAH et al. The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis. Pathog Glob Health 2022; 116 (5): 269–81. DOI: 10.1080/20477724.2022.2029301 148. Sotoodeh Ghorbani S, Taherpour N, Bayat S et al. Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID-19: A systematic review and meta-analysis. J Med Virol 2022; 94 (1): 44–53. DOI: 10.1002/jmv.27281 149. Mao Y, Wang W, Ma J et al. Reinfection rates among patients previously infected by SARS-CoV-2: systematic review and meta-analysis. Chin Med J (Engl) 2021; 135 (2): 145–52. DOI: 10.1097/CM9. 0000000000001892 150. Flacco ME, Acuti Martellucci C, Baccolini V et al. Risk of reinfection and disease after SARS-CoV-2 primary infection: Meta-analysis. Eur J Clin Invest 2022; 52 (10): e13845. DOI: 10.1111/eci.13845